Bloodspot cortisol, where finger pricked blood is applied to blotting paper, is suitable for repeated measurements in the home environment. The use of bloodspot cortisol measurements in children with asthma and the effect of inhaled corticosteroids on daytime cortisol concentrations were assessed. Twenty children with mild asthma were randomised to receive double blind either placebo or beclomethasone dipropionate 200 ,ug twice daily. Blood was taken by finger prick at home on waking, and treatment administered. Blood was then taken one hour after treatment, at lunchtime, and in the evening. The area under the curve (AUC) for the four time points was calculated as a composite index of daytime cortisol.
With the recognition of asthma as an inflammatory disease has come a greater use of antiinflammatory treatment, commonly inhaled corticosteroids. Inhaled corticosteroids are well recognised to have systemic side effects including decreased growth in childhood,' impaired bone metabolism,2 skin thinning with purpura,3 and suppression of the hypothalamo-pituitary-adrenal axis. 4 Detectable adrenal suppression is dependent not only on the on treatment and dosage, but crucially the method of assessing function. Dynamic tests of adrenal function such as those using tetracosactrin (Synacthen, Ciba)5, metyrapone,6 or insulin stress,7 or measurements of 24 hour urinary cortisol excretion,8 have shown little suppression of pituitary adrenal axis on up to 800 ,ug/day of corticosteroid. However integrated overnight serial plasma cortisol concentrations do show significant suppression at doses as low as 400 ,tg/day of beclomethasone dipropionate when compared with controls,8 and it is likely this is a more sensitive index of adrenal suppression. A major drawback of serial plasma cortisol measurement is the need for either repeated venesection or a patient indwelling cannula -effectively limiting patients to the hospital environment. It is also unclear what effect a dose of inhaled corticosteroid has in the short term on the pituitary-adrenal axis.
The purpose of this study was to measure the effect of a conventional dose of beclomethasone dipropionate in children had on daytime cortisol profile, and determine whether there was an effect on cortisol concentrations immediately after treatment administration.
Subjects and methods

SUBJECTS
Twenty subjects with mild asthma participating into a larger study on the effect of inhaled steroids on viral induced wheezing episodes were recruited into the study. All had either five or more wheezing episodes in the preceding year or an episode of wheezing lasting for three days or more in the preceding year. Exclusion criteria at entry included the use of inhaled or use of oral corticosteroids immediately before enrolment, or severe respiratory disease such as cystic fibrosis. Subjects were then randomised in a double blind manner to receive either beclomethasone dipropionate 200 ,ug twice daily or placebo, as dry powder via a diskhaler (Allen and Hanbury). At the time of testing all subjects had been taking the steroid or placebo for a minimum of six months and none had received any oral steroids in the preceding six months. All participants completed baseline spirometry with a dry wedge spirometer.
Subjects were shown the use of the 'Soft Touch' (Boehringer Mannheim UK) bloodletter, and application of blood onto filter paper. Only children happy to let blood themselves were entered into the study. They were asked to apply blood in duplicate to prescribed areas of the filter paper four times during the day: once immediately on getting up in the morning, one hour after taking their treatment, at midday, and in the evening before their treatment. The children were asked to inhale their medication at their usual time soon after arising. The four blood tests were then repeated on a separate day within a two week period. The samples were kept dry before analysis. Blood cortisol (nmol/l) nine girls with a mean age of years (range 029 7 1-9-9), and all children were prepubertal.
I-01
Eight children were receiving beclomethasone -dipropionate and 12 were receiving placebo.
There were no significant differences in sex a conventional dose of beclomethasone dipropionate of 400 ,ug/day. Our groups were well stribution, age, forced expiratory volume in matched, with the only difference by chance le second, or height between the treatment between the two groups being that the group oups. However, the beclomethasone dipro-on beclomethasone dipropionate were signifionate group were significantly heavier and cantly heavier and had greater surface area. id significantly greater surface area than the These differences are if anything likely to mask acebo group. significant suppression of the pituitary axis in the beclomethasone dipropionate group. Thus the differences we observed are likely to be due 'FECT OF INHALED CORTICOSTEROIDS to the treatment and not the disease. Tests of Lean (SEM) cortisol concentrations fell pituitary-adrenal function on inhaled corticos-,nificantly over the course of the day from teroid treatment have given apparently contra-)9-2 (15.6) nmolll on arising to 58-4 (8-9) dictory results. Many studies have shown no nol/l in the evening. Mean cortisols for the significant adrenal suppression on a daily dose ur times during the day both on beclometha-of 400 ,ug of inhaled corticosteroid,5 10-14 or ne dipropionate and on placebo are pre-even up to 800 pug/day.'5 16 Others have shown nted in table 2. Mean cortisol concentrations suppression on daily doses ranging from 300 -re lower in the beclomethasone dipropi-,ug to 800 ,ug. 4 17-19 However, many of these late treated group compared with the studies have used relatively insensitive stimulaacebo treated group at all four time points, tion tests, or the even less sensitive 8.00 am it only reached significance at the collection cortisol concentration. It is now accepted e hour after inhalation of treatment and at that integrated tests of adrenal function are e midday collection (fig 2) . When the AUC superior to stimulation testing, either timed is used as an integrated function of daytime urinary cortisol measurements20 or preferably vels, again the beclomethasone dipropionate serial plasma cortisol measurements.21 oup had significantly lower concentrations Integrated plasma cortisol studies, where an the placebo group (316-9 (31 4) v 445-5 subjects are admitted overnight and blood 9.7), p=0011). There was no significant sampled every 20 minutes via an indwelling fference in cortisols at any of the four time cannula for measurement of plasma cortisol, ints or in the AUC between the sexes. There have shown diminished adrenal function on is no significant correlation between the inhaled corticosteroids. A cross sectional study UC and height, weight, or surface area of the in 19 asthmatic children, 12 of whom were Lildren.
receiving inhaled beclomethasone dipropionate, showed a dose dependent decrease in integrated overnight plasma cortisol. A possible alternative to plasma cortisol would be salivary cortisol measurement, which has also been shown to be suppressed during the daytime in children with asthma receiving inhaled corticosteroids.23 The disadvantage of salivary cortisol is the need to rapidly freeze samples to -20°C, so diminishing its appeal for serial measurements outside the hospital environment. We feel bloodspot cortisol is superior because, as long as it is kept dry, the sample may be stored for up to three months before analysis (unpublished). Measurement of bloodspot cortisol combines both simplicity of collection and ready acceptability to most children. It is clear that sensitive indices of the pituitary-adrenal axis are suppressed in children receiving inhaled corticosteroids. However, the functional significance of suppression of biochemical indices of pituitaryadrenal axis function remains unclear. It is salient to note that despite the widespread use of inhaled corticosteroids only two cases of resultant acute adrenal insufficiency have been reported, in one adult24 and one child.25 We feel that until there is a clearer understanding of the long term side effects of inhaled corticosteroids it is important to document their potential adverse effects, but that for the time being they must remain the mainstay of treatment for the child with moderate to severe asthma.
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